BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

397 related articles for article (PubMed ID: 32742135)

  • 1. Type I and type II
    Yuan L; Zhao JB; Zhou YL; Qi YB; Guo QY; Zhang HH; Khan MN; Lan L; Jia CH; Zhang YR; Ding SZ
    World J Gastroenterol; 2020 Jul; 26(25):3673-3685. PubMed ID: 32742135
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of serum pepsinogens and gastrin-17 with
    Zhou JP; Liu CH; Liu BW; Wang YJ; Benghezal M; Marshall BJ; Tang H; Li H
    Front Cell Infect Microbiol; 2022; 12():980399. PubMed ID: 36051244
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement in serum pepsinogens and gastrin in long-term monitoring after eradication of Helicobacter pylori: comparison with H. pylori-negative patients.
    Ohkusa T; Miwa H; Nomura T; Asaoka D; Kurosawa A; Sakamoto N; Abe S; Hojo M; Terai T; Ogihara T; Sato N
    Aliment Pharmacol Ther; 2004 Jul; 20 Suppl 1():25-32. PubMed ID: 15298602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Relationship between pepsinogen I/II ratio and age or upper gastrointestinal diseases in Helicobacter pylori-positive and -negative subjects].
    Paik CN; Chung IS; Nam KW; Kwon JH; Chang JH; Suh JP; Park JM; Cho YK; Lee IS; Kim SW; Choi MG
    Korean J Gastroenterol; 2007 Aug; 50(2):84-91. PubMed ID: 17928751
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer development based on chronic active gastritis and resulting gastric atrophy as assessed by serum levels of pepsinogen and Helicobacter pylori antibody titer.
    Yoshida T; Kato J; Inoue I; Yoshimura N; Deguchi H; Mukoubayashi C; Oka M; Watanabe M; Enomoto S; Niwa T; Maekita T; Iguchi M; Tamai H; Utsunomiya H; Yamamichi N; Fujishiro M; Iwane M; Takeshita T; Ushijima T; Ichinose M
    Int J Cancer; 2014 Mar; 134(6):1445-57. PubMed ID: 24009139
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serological assessment of gastric intestinal metaplasia and atrophy using pepsinogen-I, pepsinogen-II and gastrin-17 levels in a low incidence area of gastric cancer endemic for H. pylori infection.
    Ghoshal UC; Kumar S; Krishnani N; Kumari N; Chourasia D; Tripathi S
    Trop Gastroenterol; 2011; 32(4):292-8. PubMed ID: 22696910
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The association between precancerous gastric lesions and serum pepsinogens, serum gastrin, vascular endothelial growth factor, serum interleukin-1 Beta, serum toll-like receptor-4 levels and Helicobacter pylori Cag A status.
    Yakut M; Örmeci N; Erdal H; Keskin O; Karayel Z; Tutkak H; Soykan I
    Clin Res Hepatol Gastroenterol; 2013 Jun; 37(3):302-11. PubMed ID: 23137754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Family-based
    Yu XC; Shao QQ; Ma J; Yu M; Zhang C; Lei L; Zhou Y; Chen WC; Zhang W; Fang XH; Zhu YZ; Wu G; Wang XM; Han SY; Sun PC; Ding SZ
    World J Gastroenterol; 2022 Jul; 28(28):3706-3719. PubMed ID: 36161052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Screening of atrophic gastritis and gastric cancer by serum pepsinogen, gastrin-17 and Helicobacter pylori immunoglobulin G antibodies.
    Cao Q; Ran ZH; Xiao SD
    J Dig Dis; 2007 Feb; 8(1):15-22. PubMed ID: 17261130
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Seroepidemiology of gastritis in Japanese and Dutch working populations: evidence for the development of atrophic gastritis that is not related to Helicobacter pylori.
    Schlemper RJ; van der Werf SD; Vandenbroucke JP; Biemond I; Lamers CB
    Gut; 1995 Aug; 37(2):199-204. PubMed ID: 7557568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Basal concentrations of gastrin and pepsinogen I and II in gastric ulcer: influence of Helicobacter pylori infection and usefulness in the control of the eradication].
    Bermejo F; Boixeda D; Gisbert JP; Sanz JM; Defarges V; Alvarez Calatayud G; Moreno L; Martín de Argila C
    Gastroenterol Hepatol; 2001 Feb; 24(2):56-62. PubMed ID: 11247290
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Relationship between Helicobacter pylori infection, atrophic gastritis and gastric carcinoma in a Japanese population.
    Asaka M; Kato M; Kudo M; Katagiri M; Nishikawa K; Yoshida J; Takeda H; Miki K
    Eur J Gastroenterol Hepatol; 1995 Aug; 7 Suppl 1():S7-10. PubMed ID: 8574741
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gastric carcinoid tumors without autoimmune gastritis in Japan: a relationship with Helicobacter pylori infection.
    Sato Y; Iwafuchi M; Ueki J; Yoshimura A; Mochizuki T; Motoyama H; Sugimura K; Honma T; Narisawa R; Ichida T; Asakura H; Van Thiel DH
    Dig Dis Sci; 2002 Mar; 47(3):579-85. PubMed ID: 11911346
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A retrospective study assessing the acceleration effect of type I Helicobacter pylori infection on the progress of atrophic gastritis.
    Liu W; Tian J; Hui W; Kong W; Feng Y; Si J; Gao F
    Sci Rep; 2021 Feb; 11(1):4143. PubMed ID: 33603125
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence of H. pylori infection and atrophic gastritis among symptomatic and dyspeptic adults in Kazakhstan. A hospital-based screening study using a panel of serum biomarkers.
    Benberin V; Bektayeva R; Karabayeva R; Lebedev A; Akemeyeva K; Paloheimo L; Syrjänen K
    Anticancer Res; 2013 Oct; 33(10):4595-602. PubMed ID: 24123036
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Characteristics of gastric cancer in negative test of serum anti-Helicobacter pylori antibody and pepsinogen test: a multicenter study.
    Kiso M; Yoshihara M; Ito M; Inoue K; Kato K; Nakajima S; Mabe K; Kobayashi M; Uemura N; Yada T; Oka M; Kawai T; Boda T; Kotachi T; Masuda K; Tanaka S; Chayama K
    Gastric Cancer; 2017 Sep; 20(5):764-771. PubMed ID: 28025702
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between Helicobacter pylori status and serum pepsinogens as serologic markers in atrophic gastritis.
    Bölükbaş C; Bölükbaş FF; Ovünç O; Kiliç G; Dalay R; Güven H; Uras F; Yardimci TK; Sökmen MH; Agan AF; Pişkinpaşa N
    Turk J Gastroenterol; 2006 Sep; 17(3):172-6. PubMed ID: 16941249
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Low Pepsinogen I/II Ratio and High Gastrin-17 Levels Typify Chronic Atrophic Autoimmune Gastritis Patients With Gastric Neuroendocrine Tumors.
    Magris R; De Re V; Maiero S; Fornasarig M; Guarnieri G; Caggiari L; Mazzon C; Zanette G; Steffan A; Canzonieri V; Cannizzaro R
    Clin Transl Gastroenterol; 2020 Sep; 11(9):e00238. PubMed ID: 33094954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma ghrelin concentration correlates with the levels of serum pepsinogen I and pepsinogen I/II ratio--a possible novel and non-invasive marker for gastric atrophy.
    Suzuki H; Masaoka T; Hosoda H; Nomura S; Ohara T; Kangawa K; Ishii H; Hibi T
    Hepatogastroenterology; 2004; 51(59):1249-54. PubMed ID: 15362725
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Helicobacter pylori, pepsinogens and gastrin: relationship with age and development of atrophic gastritis.
    Kuipers EJ; Pals G; Peña AS; van Uffelen CW; Kok A; Westerveld BD; Meuwissen SG
    Eur J Gastroenterol Hepatol; 1996 Feb; 8(2):153-6. PubMed ID: 8723421
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.